MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 91 filers reported holding MYOVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $487,005 | -56.8% | 18,064 | -71.2% | 0.00% | – |
| Q3 2022 | $1,127,000 | +104.5% | 62,764 | +41.6% | 0.00% | – |
| Q2 2022 | $551,000 | -69.5% | 44,321 | -67.3% | 0.00% | – |
| Q1 2022 | $1,807,000 | -4.4% | 135,597 | +11.6% | 0.00% | – |
| Q4 2021 | $1,891,000 | -8.2% | 121,473 | +32.3% | 0.00% | – |
| Q3 2021 | $2,060,000 | -58.9% | 91,782 | -58.3% | 0.00% | -100.0% |
| Q2 2021 | $5,017,000 | +48.1% | 220,293 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $3,388,000 | -38.6% | 164,655 | -17.6% | 0.00% | -33.3% |
| Q4 2020 | $5,517,000 | +50.8% | 199,740 | -23.3% | 0.00% | +50.0% |
| Q3 2020 | $3,659,000 | +67.8% | 260,423 | +146.1% | 0.00% | +100.0% |
| Q2 2020 | $2,181,000 | +483.2% | 105,800 | +338.2% | 0.00% | 0.0% |
| Q4 2019 | $374,000 | – | 24,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |